Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.34K Sell
1,346
-101
-7% -$596 ﹤0.01% 544
2026
Q1
$5.95K Buy
1,447
+174
+14% +$843 ﹤0.01% 598
2025
Q4
$8.46K Sell
1,273
-119
-9% -$806 ﹤0.01% 591
2025
Q3
$8.55K Sell
1,392
-229
-14% -$1.79K ﹤0.01% 567
2025
Q2
$14.9K Hold
1,621
﹤0.01% 527
2025
Q1
$19.5K Buy
1,621
+291
+22% +$3.81K ﹤0.01% 505
2024
Q4
$14.7K Buy
+1,330
New +$18.7K ﹤0.01% 501

Other funds holding EOLS

GF Fund Management's EOLS Position: Q2 2026 in Review

GF Fund Management reduced its Evolus (EOLS) stake by 7% in Q2 2026, selling an estimated $596 and leaving 1,346 shares worth $9.34K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

GF Fund Management first reported a position in EOLS in Q4 2024 and has held it in 7 quarters since. The position peaked at $19.5K in Q1 2025. 159 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • GF Fund Management held 1,346 shares of Evolus worth $9.34K as of Q2 2026.
  • GF Fund Management sold 101 Evolus shares in Q2 2026, an estimated $596.
  • Evolus made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #544 holding.
  • GF Fund Management first reported a position in Evolus in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Evolus position peaked at $19.5K in Q1 2025.
  • 159 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.